Literature DB >> 8041626

Sequence specificity of the non-natural pyrido[2,3-d]pyrimidine nucleoside in triple helix formation.

A B Staubli1, P B Dervan.   

Abstract

The non-natural pyrido[2,3-d]pyrimidine nucleoside F, which pairs preferentially with guanine (G) and adenine (A) within double-helical DNA, recognizes with high selectivity AT base pairs within triple-helical complexes. These observations suggest that F may exist in different tautomeric forms within double-helical and triple-helical complexes. Analysis of the base stacking properties of this extended ring system using two oligodeoxyribonucleotides containing terminal thymines and/or pyrido[2,3-d]pyrimidines bound to adjacent sites showed a decrease in free energy of binding in a triple-helical complex in the order (5'-3') TT > FT > TF > FF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041626      PMCID: PMC308221          DOI: 10.1093/nar/22.13.2637

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  NMR studies of triple-strand formation from the homopurine-homopyrimidine deoxyribonucleotides d(GA)4 and d(TC)4.

Authors:  P Rajagopal; J Feigon
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

2.  Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.

Authors:  M Cooney; G Czernuszewicz; E H Postel; S J Flint; M E Hogan
Journal:  Science       Date:  1988-07-22       Impact factor: 47.728

3.  Base stacking and molecular polarizability: effect of a methyl group in the 5-position of pyrimidines.

Authors:  L C Sowers; B R Shaw; W D Sedwick
Journal:  Biochem Biophys Res Commun       Date:  1987-10-29       Impact factor: 3.575

4.  Sequence-specific cleavage of double helical DNA by triple helix formation.

Authors:  H E Moser; P B Dervan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

5.  Recognition of thymine adenine.base pairs by guanine in a pyrimidine triple helix motif.

Authors:  L C Griffin; P B Dervan
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

6.  Synthesis and hybridization of dodecadeoxyribonucleotides containing a fluorescent pyridopyrimidine deoxynucleoside.

Authors:  H Inoue; A Imura; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

7.  Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[alpha]-thymidylate covalently linked to an azidoproflavine derivative.

Authors:  T Le Doan; L Perrouault; D Praseuth; N Habhoub; J L Decout; N T Thuong; J Lhomme; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-10-12       Impact factor: 16.971

8.  Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product.

Authors:  N D Sinha; J Biernat; J McManus; H Köster
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

9.  Specific recognition of CG base pairs by 2-deoxynebularine within the purine.purine.pyrimidine triple-helix motif.

Authors:  H U Stilz; P B Dervan
Journal:  Biochemistry       Date:  1993-03-09       Impact factor: 3.162

10.  Sequence-specific cleavage of single-stranded DNA: oligodeoxynucleotide-EDTA X Fe(II).

Authors:  G B Dreyer; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  2 in total

1.  Quinazoline-2,4(1H,3H)-dione as a substitute for thymine in triple-helix forming oligonucleotides: a reassessment.

Authors:  J Michel; J J Toulmé; J Vercauteren; S Moreau
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

2.  Four base recognition by triplex-forming oligonucleotides at physiological pH.

Authors:  David A Rusling; Vicki E C Powers; Rohan T Ranasinghe; Yang Wang; Sadie D Osborne; Tom Brown; Keith R Fox
Journal:  Nucleic Acids Res       Date:  2005-05-23       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.